Teva has launched a new patient portal in the U.S. for asthma, ADHD, depression and migraines that it hopes to expand with more conditions and geographies such as Europe.
“Life Effects is an ongoing connection with patients rather than a one-off campaign,” said Iris Beck-Codner, executive vice president at Teva for global brand and corporate communications. “We’re working with patient groups and contributors on an ongoing basis … to tap the knowledge and experience of patients themselves to bridge the information gap.”
The portal is expected to be more than just information, it will include tools and activities. The platform is starting with significant promotion:
Teva will drive people to the site through digital and social media—such as highly targeted Facebook paid promotions as well as through its accounts on LinkedIn, Twitter and Facebook—with the goal to raise more organic traffic over time, Beck-Codner said.
Other stories from the Fierce network:
- Neural network bests dermatologists in lesion classification test
- Ambien made me racist? No way, Sanofi tells Roseanne, and its tweet goes viral
